ライフサイエンスコーパス: brachial artery

1 improves flow-mediated dilation (FMD) of the brachial artery.

2 nd nitroglycerin-induced vasodilation of the brachial artery.

3 asound to measure changes in diameter of the brachial artery.

4 ans of flow-mediated dilatation (FMD) of the brachial artery.

5 lation (NID; endothelium independent) of the brachial artery.

6 ) were assessed by ultrasound imaging of the brachial artery.

7 or measuring flow-mediated dilatation of the brachial artery.

8 studies were performed by infusion into the brachial artery.

9 ction and cold pressor responsiveness of the brachial artery.

10 ed by high-resolution ultrasonography of the brachial artery.

11 stischemic flow-mediated vasodilation of the brachial artery.

12 gs and electrolytes were infused through the brachial artery.

13 etected by cuff pressure measurements in the brachial artery.

14 s improved flow-mediated vasodilation of the brachial artery.

15 t and -independent vascular responses of the brachial artery.

16 -1). min(-1), n = 9) or saline (n = 8) via a brachial artery.

17 maging and cuff pressure measurements in the brachial artery.

18 -induced flow-mediated dilation (FMD) of the brachial artery.

19 essed by flow-mediated dilation (FMD) of the brachial artery.

20 aneous low-frequency US energy dilates human brachial arteries.

21 neous low-frequency ultrasound (US) in human brachial arteries.

22 lved (femoral and popliteal) and uninvolved (brachial) arteries.

23 in endothelial cells (ECs) obtained from the brachial artery (1.25+/-0.12 versus 0.61+/-0.11 nitrotyr

24 endothelium-dependent dilation (EDD) of the brachial artery; 2) combined serum nitrite/nitrate (NOx)

25 t, we assessed (1) flow-mediated dilation of brachial artery; (2) coronary flow reserve, ejection fra

26 and autologously transfused into the forearm brachial artery 5 and 42 days after blood donation.

27 Flow-mediated dilation (FMD) of the brachial artery, a measure of endothelial function, was

28 nt vasodilation was measured via incremental brachial artery administration of methacholine chloride

29 ent vasodilation was measured by incremental brachial artery administration of methacholine chloride

30 nous occlusion plethysmography) responses to brachial artery administration of prazosin (an alpha(1)-

31 by measuring changes in the diameter of the brachial artery after 5 minutes of arterial occlusion.

32 Brachial artery and antecubital vein catheters were plac

33 y) for 45 min with catheters inserted in the brachial artery and both femoral veins.

34 Flow-mediated dilation (FMD) of the brachial artery and E-selectin, von Willebrand factor, a

35 ysfunction in CHF, as assessed by FMD in the brachial artery and exhaled NO production during submaxi

36 ressed by a smaller percentage of FMD of the brachial artery and higher salivary levels of MMP-2/TIMP

37 Blood was sampled simultaneously from the brachial artery and internal jugular and femoral veins w

38 etal blood samples were drawn from the fetal brachial artery and jugular veins at several time points

39 Catheters were placed in the brachial artery and sagittal sinus vein for collection o

40 essed by flow-mediated dilation (FMD) of the brachial artery and TR jet velocity, respectively.

41 al function (flow-mediated dilatation of the brachial artery) and cardiac function were also measured

42 ulation (flow-mediated dilation [FMD] in the brachial artery) and the pulmonary circulation (exhaled

43 Elite power athletes have larger brachial arteries, and greater vasoreactivity (greater v

44 lood pressure, flow-mediated dilation in the brachial artery, and carotid to radial pulse wave veloci

45 ction by flow-mediated dilation (FMD) of the brachial artery, and evaluated central arterial stiffnes

46 Immediate left brachial artery angiography with subsequent thrombectomy

47 ; similar effects were also observed for the brachial artery ( approximately 25% decrease in blood fl

48 ndent (glyceryl trinitrate [GTN]) changes in brachial artery area were measured using cardiovascular

49 ges in flow-mediated dilatation (FMD) of the brachial artery, arterial stiffness, and blood pressure.

50 ll women using flow-mediated dilation of the brachial artery at 23-25 weeks' gestation.

51 hemia induced by a surgical occlusion of the brachial artery (BAO) induces increased paw-guarding beh

52 ood pressure, mean arterial pressure (MAP)], brachial artery blood flow ( Q (BA) ), FVC ( Q (BA) /MAP

53 lamp)) and endothelial function evaluated by brachial artery blood flow (BAF; Doppler ultrasound) and

54 croneurography), arterial blood pressure and brachial artery blood flow (duplex Doppler ultrasound) w

55 am), oxygen saturation (pulse oximetry), and brachial artery blood flow and shear rate (ultrasound) w

56 We assessed brachial artery blood flow during maximal handgrip exerc

57 scle microvascular recruitment and increased brachial artery blood flow seen in lean individuals.

58 nges in blood pressure (Finapres) divided by brachial artery blood flow velocity (Doppler ultrasound)

59 Studies included brachial artery blood pressure (BP), aortic pulse wave v

60 isease, simple measurements such as standard brachial artery blood pressure, brachial pulse pressure,

61 he assessment of endothelial function in the brachial artery by flow-mediated dilatation (FMD).

62 nt (nitroglycerin) vascular responses of the brachial artery by high-resolution ultrasound imaging.

63 s (IMT), flow-mediated vasodilatation of the brachial artery by ultrasound, assessment of endothelial

64 he assessment of endothelial function in the brachial artery by using flow-mediated dilation.

65 sed local stiffness of carotid, femoral, and brachial arteries (by ultrasonography), carotid-femoral

66 (r = -0.301, p = 0.008), and the presence of brachial artery calcification (r = -0.178, p = 0.036).

67 Subsequently, AA was infused via brachial artery catheter for 10 min during continued exe

68 n alpha1 -adrenoceptor agonist) infusion via brachial artery catheter in response to two different st

69 aline or drugs were infused sequentially via brachial artery catheter in the exercising forearm.

70 used (2 ml x min(-1)) into the forearm via a brachial artery catheter to locally inhibit synthesis of

71 the first five subjects, arterial pressure (brachial artery catheter) and forearm blood flow (plethy

72 alpha- and beta-adrenoceptor blockade (via a brachial artery catheter) to eliminate sympathoadrenal i

73 ioxidant vitamin therapy improved FMD of the brachial artery compared with baseline (P<0.001) without

74 therapy were not apparent from conventional brachial artery cuff pressure assessments.

75 inly rely on blood pressure (BP) measured at brachial arteries (cuff BP).

76 In contrast, brachial artery DC progressively increased from baseline

77 The postischemic flow-mediated dilation of brachial artery decreased from 6.3 +/- 1.1% at baseline

78 Before and after each exposure, brachial artery diameter (BAd) was assessed using ultras

79 Brachial artery diameter (BAD) was measured by ultrasoun

80 egressions were fit to the percent change in brachial artery diameter (flow mediated and nitroglyceri

81 nd P = 0.005, respectively) alongside larger brachial artery diameter (P = 0.015) and lower FMD perce

82 several biomarkers were related to baseline brachial artery diameter (PAI-1, CRP, urine albumin-crea

83 blood pressure, heart rate, and simultaneous brachial artery diameter and blood velocity were recorde

84 Insulin increased brachial artery diameter and flow in the lean but not in

85 ose clamp) and insulin-stimulated changes in brachial artery diameter and forearm skeletal muscle cap

86 There was no difference in baseline brachial artery diameter between the two groups.

87 Changes in brachial artery diameter during reactive hyperemia were

88 fish consumption and a 0.10-mm lower (1 SD) brachial artery diameter in men (P = 0.01) and a 0.27% s

89 ultrasound was used to measure the change in brachial artery diameter in response to reactive hyperem

90 and EID were measured as percent increase in brachial artery diameter in response to reactive hyperem

91 At 5 min of US, the brachial artery diameter increased by 4.1%.

92 FMD and brachial artery diameter may have similar predictive val

93 Brachial artery diameter was also predictive of CV event

94 2 wk increased insulin-stimulated changes in brachial artery diameter when compared with placebo [med

95 Brachial artery diameter, a predictor of cardiovascular

96 olution ultrasound and Doppler, we evaluated brachial artery diameter, blood flow, and forearm vascul

97 onography was used to measure alterations in brachial artery diameter, endothelial-dependent flow-med

98 (p = 0.010) after controlling for changes in brachial artery diameter, reactive hyperemia, low-densit

99 esolution ultrasonography was used to assess brachial artery diameters at rest and following 5 minute

100 It was hypothesized brachial artery diameters of athletes would be larger, h

101 Brachial artery diameters were measured at rest and 1 mi

102 Brachial artery diameters were measured before and after

103 scular parameters, including: 1) carotid and brachial artery diameters, intima-media thickness, compl

104 Endothelial-dependent and -independent brachial artery dilatation were also assessed by cine MR

105 Brachial arteries dilated in response to sildenafil in c

106 erformed at 1 month after surgery, and early brachial artery dilation was defined as the change in po

107 Flow-mediated brachial artery dilation was measured by ultrasound.

108 heart rate, but had no significant effect on brachial artery dilation.

109 re was no significant effect of treatment on brachial artery dilation.

110 ion, vascular ultrasound was used to measure brachial artery distensibility in 294 healthy adolescent

111 Brachial artery distensibility was measured by a noninva

112 sessed by measurement of the diameter of the brachial artery during flow (flow-mediated dilatation),

113 However, the predictive value of brachial artery endothelial dysfunction for future cardi

114 effect of a low-fat spread with added PSs on brachial artery endothelial function as measured by flow

115 idant vitamins C and E improves coronary and brachial artery endothelial function in patients with co

116 Impaired brachial artery endothelial function independently predi

117 Brachial artery endothelial function is impaired in indi

118 etylcholine infusions (n = 18 patients), and brachial artery endothelial function was assessed by flo

119 Brachial artery endothelial function was assessed by vas

120 Brachial artery endothelial function, pulmonary function

121 onance imaging; measurement of flow-mediated brachial artery endothelial vasodilation, carotid intima

122 Cardiovascular profiles, brachial artery endothelial-dependent flow-mediated dila

123 ly examine the long-term predictive value of brachial-artery endothelial dysfunction for future cardi

124 otid endarterectomy, p = 0.02), and impaired brachial-artery endothelial function (p = 0.002).

125 Impaired brachial-artery endothelial function independently predi

126 Brachial-artery endothelial function is impaired in indi

127 We examined brachial-artery endothelial function using ultrasound in

128 velocity; 3) coronary calcification; and 4) brachial artery endothelium-dependent and -independent v

129 Brachial artery endothelium-independent dilatation (subl

130 Higher resting brachial artery flow (OR, 1.23 [95% CI, 1.04-1.46]) and

131 During each trial, brachial artery flow mediated dilation (FMD) was used to

132 nd following 5 minutes of forearm occlusion (Brachial Artery Flow Mediated Dilation = BAFMD) and a co

133 ous and venous plasma carnitine difference x brachial artery flow), and carnitine disappearance (Rd)

134 We also measured brachial artery flow, fasting lipid profile, and anthrop

135 At baseline, brachial artery flow-mediated dilatation (FMD) was 55% l

136 Endothelial function assessed by brachial artery flow-mediated dilatation (FMD) was measu

137 Carotid intima-media thickness (IMT) and brachial artery flow-mediated dilatation (FMD) were meas

138 Brachial artery flow-mediated dilatation (FMD), normaliz

139 in [Hb] and haematocrit (Hct) would increase brachial artery flow-mediated dilatation (FMD).

140 systemic vasculature was investigated using brachial artery flow-mediated dilatation and carotid art

141 METHODS AND Brachial artery flow-mediated dilatation and cIMT were m

142 ic haemodilution led to a marked increase in brachial artery flow-mediated dilatation in humans The i

143 d endothelial function was assessed from the brachial artery flow-mediated dilatation response.

144 Brachial artery flow-mediated dilatation was determined

145 Brachial artery flow-mediated dilatation was measured at

146 ve was to quantify endothelial function (via brachial artery flow-mediated dilatation) at sea level (

147 ve was to quantify endothelial function (via brachial artery flow-mediated dilatation) at sea level (

148 pressure, uterine artery pulsatility index, brachial artery flow-mediated dilatation, and serum conc

149 controlled pilot study, we observed improved brachial artery flow-mediated dilation (7.7 +/- 2.9% to

150 hed non-smoking control subjects we examined brachial artery flow-mediated dilation (FMD) and circula

151 Brachial artery flow-mediated dilation (FMD) and nitrogl

152 we measured plasma nicotine, exhaled CO, and brachial artery flow-mediated dilation (FMD) before and

153 ndpoint was the week 24 within-arm change in brachial artery flow-mediated dilation (FMD) in particip

154 Although brachial artery flow-mediated dilation (FMD) predicts re

155 Brachial artery flow-mediated dilation (FMD) was determi

156 lood were collected from a forearm vein, and brachial artery flow-mediated dilation (FMD) was measure

157 was reconstructed by mathematical modeling; brachial artery flow-mediated dilation (FMD) was measure

158 pressure, aortic pulse wave velocity (PWV), brachial artery flow-mediated dilation (FMD), and serum

159 examined a measure of endothelial function, brachial artery flow-mediated dilation (FMD), expressed

160 take and brachial artery measures, including brachial artery flow-mediated dilation (FMD), has not be

161 Brachial artery flow-mediated dilation (FMD), urinary 8-

162 Endothelial function was evaluated by brachial artery flow-mediated dilation (FMD).

163 Primary endpoints were safety and brachial artery flow-mediated dilation (FMD).

164 eactivity as indexed by direct assessment of brachial artery flow-mediated dilation (FMD).

165 ammatory markers and vascular function using brachial artery flow-mediated dilation (FMD).

166 Coprimary end points included change in brachial artery flow-mediated dilation (FMDBA) and aorti

167 .5% women; mean age, 62 years) with measured brachial artery flow-mediated dilation (n=1446) or hyper

168 .03), noncarotid surgery (P=0.05), and lower brachial artery flow-mediated dilation (P=0.007).

169 ly 50% (to 70 +/- 30 mmol/day), and conduit (brachial artery flow-mediated dilation [FMD(BA)]) and re

170 Endothelial function (brachial artery flow-mediated dilation [FMD]) was measur

171 mary end point was change in maximal percent brachial artery flow-mediated dilation after exposure.

172 A strong inverse relation between brachial artery flow-mediated dilation and increasing qu

173 s measured by enzyme-linked immunoassay, and brachial artery flow-mediated dilation and nitroglycerin

174 ignificantly increased endothelium-dependent brachial artery flow-mediated dilation at 16 weeks, wher

175 outcome was change in endothelium-dependent brachial artery flow-mediated dilation at 16 weeks.

176 Salsalate increased brachial artery flow-mediated dilation by 74% (from 4.0+

177 er high-density lipoprotein cholesterol, and brachial artery flow-mediated dilation compared with lea

178 Infusion of vitamin C increased brachial artery flow-mediated dilation during placebo (P

179 with high-resolution ultrasound to determine brachial artery flow-mediated dilation in 50 pediatric h

180 Ultrasound assessment of brachial artery flow-mediated dilation is emerging as a

181 Bruce protocol), applanation tonometry, and brachial artery flow-mediated dilation testing.

182 nded particles, the absolute maximal percent brachial artery flow-mediated dilation was reduced by 0.

183 ll testing, and endothelial assessment using brachial artery flow-mediated dilation were obtained at

184 on raises the possibility that assessment of brachial artery flow-mediated dilation will be useful in

185 The change in brachial artery flow-mediated dilation with salsalate wa

186 ced endothelial dysfunction (as evaluated by brachial artery flow-mediated dilation) after 8 hours.

187 EDD (brachial artery flow-mediated dilation) was approximatel

188 Brachial artery flow-mediated dilation, 24-hour urinary

189 that sleep apnea is associated with impaired brachial artery flow-mediated dilation, a surrogate of e

190 scular dysfunction, as evidenced by impaired brachial artery flow-mediated dilation, abnormal cerebra

191 Endothelial function was assessed as brachial artery flow-mediated dilation, and microvascula

192 performance, treadmill walking performance, brachial artery flow-mediated dilation, and quality of l

193 Brachial artery flow-mediated dilation, digital pulse am

194 endothelial function in humans, we measured brachial artery flow-mediated dilation, reactive hyperem

195 For brachial artery flow-mediated dilation, those in the tre

196 Secondary outcomes were brachial artery flow-mediated dilation, treadmill walkin

197 Vascular reactivity was measured by brachial artery flow-mediated dilation.

198 We measured vascular endothelial function by brachial artery flow-mediated dilation.

199 Brachial artery flow-mediated EDV was reduced in FH+ (7.

200 Brachial artery flow-mediated endothelium-dependent vaso

201 Brachial artery flow-mediated vasodilation (FMD) (1.3 vs

202 In 10 of 20 subjects, brachial artery flow-mediated vasodilation (FMD) was mea

203 Primary endpoints were changes in brachial artery flow-mediated vasodilation (FMD), caroti

204 The primary outcome was the change in brachial artery flow-mediated vasodilation (FMD).

205 Oral glucose tolerance and brachial artery flow-mediated, endothelium-dependent vas

206 scular ultrasonography was used to determine brachial artery, flow-mediated, endothelium-dependent, a

207 However, brachial artery FMD (ET: 3.8 +/- 3.0% vs. CT: 4.3 +/- 3.

208 Peak Vo2, brachial artery FMD in response to cuff ischemia, caroti

209 Brachial artery FMD increased by ~160% from 3.8 +/- 2.1

210 ntervention induced significant decreases in brachial artery FMD of all groups (P < 0.05).

211 METHODS AND Brachial artery FMD was measured in a nested case-cohort

212 P < 0.05) in femoral Delta Q , popliteal and brachial artery FMD%, respectively, occurred in both PS

213 tudies assessing carotid IMT and 7 assessing brachial artery FMD%.

214 Brachial artery FMD, carotid-femoral PWV, central AIx, a

215 ughout each exercise bout and in response to brachial artery FMD, measured prior to, immediately afte

216 ive assessment of endothelial function using brachial-artery FMD may serve as a surrogate end point f

217 ved insulin (0.05 mU. kg(-1). min(-1)) via a brachial artery for 4 h under euglycemic conditions.

218 al impairs flow-mediated vasodilation of the brachial artery for at least 4 h; however, co-ingestion

219 ssessed vascular resistance responses in the brachial artery from changes in blood pressure (Finapres

220 sured as flow-mediated dilation (FMD) of the brachial artery, has not been systematically assessed be

221 easured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period comp

222 d by using high-resolution ultrasound in the brachial artery in 64 coarctation patients (44 males and

223 itamins on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemi

224 essed by flow-mediated dilation (FMD) in the brachial artery in response to reactive hyperemia.

225 itroglycerin-mediated dilation or CPT of the brachial artery in the 2 populations.

226 s evaluated by flow-mediated dilation of the brachial artery in vivo and by vasomotor studies in saph

227 Flow-mediated dilatation of the brachial artery increased in the intervention group as c

228 asure forearm blood flow responses to graded brachial artery infusions of the beta-agonist isoprotere

229 the vascular conductance (FVC) responses to brachial artery infusions of two doses of tyramine (evok

230 the vascular conductance (FVC) responses to brachial artery infusions of tyramine (which evokes endo

231 (compared with <10%) significantly improved brachial artery macrovascular flow-mediated vasodilation

232 S AND RESULTS: Flow-mediated dilation of the brachial artery, matrix metalloproteinase-2 and matrix m

233 a similar directionality of association with brachial artery measures observed for nonfried fish cons

234 investigated cross-sectional associations of brachial artery measures with fish intake (ascertained w

235 The relation between dietary fish intake and brachial artery measures, including brachial artery flow

236 cant associations between fish intake or any brachial artery measures.

237 -6 was higher in the iliac arteries than the brachial arteries (median difference 26.5 pg/mL, this di

238 was measured by ultrasound before and after brachial artery occlusion [i.e., flow-mediated dilation

239 en consumption in the thenar eminence during brachial artery occlusion in sickle cell patients and he

240 hyl-L-arginine (L-NMMA) was infused into the brachial arteries of 9 healthy subjects for 5 minutes to

241 Brachial arteries of athletes were larger (Athletes 5.39

242 nsiveness to adenosine (ADO) infusion in the brachial arteries of human subjects.

243 is by examining pulse wave velocity (PWV) in brachial arteries of twin survivors of TTTS treated with

244 graphic examination of flow phantoms and the brachial artery of a healthy volunteer undergoing reacti

245 all levels of the aorta and the carotid and brachial artery (p > 0.05 for all).

246 lower in endothelial cells obtained from the brachial artery (P < 0.05), whereas EID did not differ.

247 trogen infusion was adjusted to reduce fetal brachial artery pO(2) by 25%.

248 essed by flow-mediated dilation (FMD) of the brachial artery preexposure, immediately postexposure, a

249 nd arterial stiffening was assessed from the brachial artery pulse pressure.

250 ssed systemic (flow-mediated dilation of the brachial artery, pulse-wave velocity, and carotid intima

251 Brachial artery reactivity (BAR) was calculated as perce

252 thickness (a measure of arterial stiffness), brachial artery reactivity (both flow-mediated dilatatio

253 Flow-mediated brachial artery reactivity test (BART) both before and 3

254 Brachial artery reactivity, using postischemic flow-medi

255 ociated with carotid intima-media thickness, brachial artery reactivity-glycerol trinitrate, serum ur

256 Endothelial function was evaluated using brachial artery reactivity.

257 Measurement of flow-mediated brachial-artery reactivity also revealed a significant r

258 greater retrograde shear likely modulate the brachial artery response, but the reduced total shear al

259 we conducted a novel assessment of vascular brachial artery responses both to ambient pollution and

260 ular ultrasound, we compared carotid IMT and brachial artery responses to reactive hyperemia (endothe

261 of 36 and 0.36 micromol/min into the forearm brachial artery resulted in supra- and near-physiologic

262 Central haemodynamics, brachial artery shear rate (SR) and blood flow profiles

263 on between nonfried fish intake and baseline brachial artery size varies by sex, with suggestive evid

264 and 6 (4%) had incident subclavian/axillary/brachial artery stenosis.

265 e impaired flow-mediated vasodilation of the brachial artery that does not improve after one year of

266 s of the dorsal pedal, posterior tibial, and brachial arteries to obtain the ankle-brachial index (AB

267 gh-frequency ultrasonographic imaging of the brachial artery to assess endothelium-dependent flow-med

268 ned from the right internal jugular vein and brachial artery to determine concentration differences f

269 ns of high-resolution ultrasonography of the brachial artery to evaluate vasomotor function, with gui

270 e low-Na+ diet, a catheter was placed in the brachial artery to measure forearm blood flow (FBF, plet

271 um-independent vasodilation were assessed by brachial artery ultrasonography.

272 FMD and BAD were measured by brachial artery ultrasound at the initial examination of

273 Brachial artery ultrasound during reactive hyperemia is

274 Measures included a brachial artery ultrasound to assess flow-mediated dilat

275 Using brachial artery ultrasound, endothelium-dependent, flow-

276 n between endothelial function determined by brachial-artery ultrasound and long-term cardiovascular

277 orphism that lowers kallikrein activity, the brachial artery undergoes eutrophic inward remodeling in

278 al, popliteal (treated with stretching), and brachial arteries (untreated) of both sides.

279 and baseline arterial diameter (BAD) of the brachial artery using ultrasound in a large multicity co

280 After 30 minutes of rest, brachial artery vascular function was assessed by ultras

281 In recent studies of brachial artery vasoactivity, a single high-fat meal red

282 osure to CAP plus ozone caused a significant brachial artery vasoconstriction compared with filtered

283 d and underwent measurement of flow-mediated brachial artery vasodilation (FMV), a measure of vascula

284 We preoperatively examined brachial artery vasodilation using ultrasound in 187 pat

285 Similarly, flow-mediated brachial artery vasodilation was impaired during hyperho

286 markers measured at a routine examination to brachial artery vasodilator function (flow-mediated dila

287 biomarkers (representing these pathways) to brachial artery vasodilator function.

288 Blood flow through the femoral and brachial arteries was recorded during whole-body tilt us

289 Flow-mediated dilation of the brachial artery was 25% smaller in ART than in control c

290 Following recovery, the brachial artery was cannulated and flushed with 10 000 U

291 -dependent flow-mediated vasodilation of the brachial artery was increased by 67%, 44%, and 75% in th

292 ent flow-mediated dilatation (ED-FMD) of the brachial artery was measured by high-resolution ultrasou

293 Flow-mediated EDV of the brachial artery was measured in 23 male patients (8 nons

294 Flow-mediated dilation of the brachial artery was measured, and CAD patients underwent

295 aorta, and the common carotid artery and the brachial artery were assessed for diastolic and systolic

296 ate, and flow-mediated dilation (FMD) of the brachial artery were evaluated in 123 study participants

297 ependent flow-mediated dilation (FMD) of the brachial artery were examined in 15 children with famili

298 and nitroglycerin-mediated reactivity of the brachial artery were measured in eight nonsmokers, seven

299 or adenosine (0.125 and 0.5 mg/min) into the brachial artery while monitoring forearm blood flow (FBF

300 ated endothelium-dependent relaxation of the brachial artery with doses of quercetin ranging from 50